Industry Trends

Glenmark unit signs exclusive licensing pact with Hansoh Pharma for NSCLC drug Aumolertinib

Under the agreement, Glenmark has received exclusive rights to develop and commercialise Aumolertinib across its licensed territories, which include the Middle East and Africa, Southeast and South Asia, Australia, New Zealand, Russia/CIS, and a few selected Caribbean countries covered by the agreement. Shares of Glenmark Pharmaceuticals Ltd ended at ₹1,962.00, down by ₹23.60, or 1.19%, on the BSE.

Industry Trends

Honor Power 2 Chipset, Display Specifications Tipped; Could Launch With 10,080mAh Battery

Honor Power 2, the rumoured successor of the Honor Power, could be equipped with a 10,080mAh battery with 80W wired fast charging support, the leaked specifications of the handset suggest. Moreover, it might launch in China as a mid-range offering in January next year. Moreover, the tech firm could equip the purported Honor Power 2 with the yet-to-be-released MediaTek Dimensity 8500 chipset, instead of a Snapdragon SoC, which powered its predecessor. The Honor Power 2 could be offered in three colourways.

Industry Trends

BEML secures ₹110 crore engine supply order from Ministry of Defence

"...we hereby inform that BEML Limited has bagged an order from the Ministry of Defence for the supply of Engines with a contract value of ₹110 crores approximately," according to a stock exchange filing. Shares of BEML Ltd ended at ₹1,703.00, down by ₹37.40, or 2.15%, on the BSE.